Levin Capital Strategies »

United Therapeutics Corporation shares owned by Levin Capital Strategies

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Levin Capital Strategies from 13F filings

Historical chart of Levin Capital Strategies investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Levin Capital Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Levin Capital Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $230k 1.0k 229.72

More positions owned by Levin Capital Strategies

Microsoft Corporation (MSFT)
O-i Glass (OI)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Caterpillar (CAT)
Ubs Group SHS (UBS)
Bank of New York Mellon Corporation (BK)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
General Motors Company (GM)
Alphabet Cap Stk Cl C (GOOG)
Cheniere Energy Com New (LNG)
Teck Resources CL B (TECK)
Apple (AAPL)

View all positions for Levin Capital Strategies

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Citigroup
Geode Capital Management
FMR
LSV Asset Management
Morgan Stanley
AQR Capital Management
Dimensional Fund Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation